Mirae Asset Global Investments’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.81M | Sell |
14,842
-4,754
| -24% | -$894K | ﹤0.01% | 720 |
|
|
2026
Q1 | $3.86M | Sell |
19,596
-142,019
| -88% | -$27.4M | ﹤0.01% | 606 |
|
|
2025
Q4 | $29.7M | Buy |
161,615
+21,333
| +15% | +$3.74M | 0.08% | 194 |
|
|
2025
Q3 | $21.5M | Sell |
140,282
-6,627
| -5% | -$1M | 0.07% | 236 |
|
|
2025
Q2 | $20.5M | Buy |
146,909
+2,176
| +2% | +$305K | 0.07% | 221 |
|
|
2025
Q1 | $21.3M | Sell |
144,733
-42,648
| -23% | -$6.17M | 0.09% | 181 |
|
|
2024
Q4 | $24.8M | Buy |
187,381
+38,593
| +26% | +$5.4M | 0.1% | 155 |
|
|
2024
Q3 | $23.1M | Buy |
148,788
+59,179
| +66% | +$9.55M | 0.1% | 154 |
|
|
2024
Q2 | $14M | Sell |
89,609
-226,052
| -72% | -$34M | 0.07% | 201 |
|
|
2024
Q1 | $43.1M | Buy |
315,661
+12,575
| +4% | +$1.67M | 0.09% | 208 |
|
|
2023
Q4 | $40.8M | Sell |
303,086
-4,227
| -1% | -$550K | 0.08% | 235 |
|
|
2023
Q3 | $41.6M | Buy |
307,313
+44,319
| +17% | +$6.05M | 0.09% | 212 |
|
|
2023
Q2 | $37.6M | Sell |
262,994
-5,604
| -2% | -$825K | 0.08% | 244 |
|
|
2023
Q1 | $37.3M | Sell |
268,598
-6,456
| -2% | -$869K | 0.09% | 237 |
|
|
2022
Q4 | $37.3M | Sell |
275,054
-5,392
| -2% | -$676K | 0.1% | 227 |
|
|
2022
Q3 | $30.8M | Sell |
280,446
-6,620
| -2% | -$840K | 0.08% | 255 |
|
|
2022
Q2 | $37.9M | Buy |
287,066
+26,578
| +10% | +$3.49M | 0.1% | 234 |
|
|
2022
Q1 | $34.6M | Buy |
260,488
+198,101
| +318% | +$23.8M | 0.07% | 296 |
|
|
2021
Q4 | $7.27M | Buy |
62,387
+13,907
| +29% | +$1.64M | 0.02% | 780 |
|
|
2021
Q3 | $5.82M | Buy |
48,480
+1,553
| +3% | +$181K | 0.01% | 804 |
|
|
2021
Q2 | $5.62M | Buy |
46,927
+12,374
| +36% | +$1.36M | 0.02% | 789 |
|
|
2021
Q1 | $3.44M | Sell |
34,553
-6,986
| -17% | -$702K | 0.01% | 823 |
|
|
2020
Q4 | $4.15M | Buy |
41,539
+3,983
| +11% | +$422K | 0.02% | 700 |
|
|
2020
Q3 | $4.12M | Sell |
37,556
-4,472
| -11% | -$497K | 0.02% | 590 |
|
|
2020
Q2 | $4.45M | Sell |
42,028
-3,815
| -8% | -$394K | 0.03% | 528 |
|
|
2020
Q1 | $4.09M | Buy |
45,843
+22,102
| +93% | +$2.08M | 0.03% | 480 |
|
|
2019
Q4 | $2.37M | Buy |
23,741
+2,574
| +12% | +$242K | 0.01% | 705 |
|
|
2019
Q3 | $1.89M | Sell |
21,167
-674
| -3% | -$58.4K | 0.01% | 722 |
|
|
2019
Q2 | $1.8M | Sell |
21,841
-23,266
| -52% | -$1.82M | 0.01% | 735 |
|
|
2019
Q1 | $3.65M | Sell |
45,107
-20,362
| -31% | -$1.6M | 0.03% | 488 |
|
|
2018
Q4 | $4.97M | Sell |
65,469
-20,702
| -24% | -$1.62M | 0.04% | 378 |
|
|
2018
Q3 | $6.82M | Sell |
86,171
-3,357
| -4% | -$254K | 0.05% | 347 |
|
|
2018
Q2 | $6.29M | Sell |
89,528
-41,859
| -32% | -$3.01M | 0.09% | 151 |
|
|
2018
Q1 | $9.19M | Buy |
131,387
+18,258
| +16% | +$1.26M | 0.12% | 118 |
|
|
2017
Q4 | $7.85M | Buy |
113,129
+2,391
| +2% | +$161K | 0.11% | 133 |
|
|
2017
Q3 | $7.5M | Sell |
110,738
-4,155
| -4% | -$262K | 0.14% | 126 |
|
|
2017
Q2 | $7.83M | Sell |
114,893
-1,481
| -1% | -$96.7K | 0.14% | 115 |
|
|
2017
Q1 | $7.25M | Sell |
116,374
-4,318
| -4% | -$251K | 0.14% | 115 |
|
|
2016
Q4 | $6.59M | Buy |
120,692
+10,405
| +9% | +$591K | 0.15% | 117 |
|
|
2016
Q3 | $7.25M | Buy |
110,287
+3,409
| +3% | +$223K | 0.15% | 104 |
|
|
2016
Q2 | $6.45M | Buy |
106,878
+5,586
| +6% | +$324K | 0.17% | 104 |
|
|
2016
Q1 | $5.71M | Buy |
101,292
+5,007
| +5% | +$301K | 0.15% | 111 |
|
|
2015
Q4 | $6.54M | Buy |
96,285
+11,450
| +13% | +$751K | 0.22% | 99 |
|
|
2015
Q3 | $5.4M | Sell |
84,835
-615
| -0.7% | -$40.5K | 0.22% | 105 |
|
|
2015
Q2 | $3.63M | Buy |
85,450
+3,900
| +5% | +$267K | 0.12% | 135 |
|
|
2015
Q1 | $5.58M | Buy |
81,550
+19,820
| +32% | +$1.38M | 0.19% | 93 |
|
|
2014
Q4 | $4.34M | Buy |
61,730
+7,490
| +14% | +$536K | 0.16% | 95 |
|
|
2014
Q3 | $3.87M | Sell |
54,240
-12,873
| -19% | -$942K | 0.14% | 92 |
|
|
2014
Q2 | $4.99M | Sell |
67,113
-1,098
| -2% | -$79.4K | 0.11% | 74 |
|
|
2014
Q1 | $4.43M | Sell |
68,211
-1,169
| -2% | -$75.5K | 0.11% | 66 |
|
|
2013
Q4 | $4.12M | Buy |
69,380
+43,850
| +172% | +$2.38M | 0.17% | 78 |
|
|
2013
Q3 | $1.33M | Buy |
25,530
+820
| +3% | +$41.2K | 0.06% | 205 |
|
|
2013
Q2 | $1.17M | Buy |
+24,710
| New | +$1.26M | 0.06% | 212 |
|
Other funds holding AZN
EPGL
RG
SAM
CDDEC
MGP
Mirae Asset Global Investments's AZN Position: Q2 2026 in Review
Mirae Asset Global Investments reduced its AstraZeneca (AZN) stake by 24% in Q2 2026, selling an estimated $894K and leaving 14,842 shares worth $2.81M. The position accounts for ﹤0.01% of the portfolio, ranked #720.
Mirae Asset Global Investments first reported a position in AZN in Q2 2013 and has held it in 53 quarters since. The position peaked at $43.1M in Q1 2024. 906 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- Mirae Asset Global Investments held 14,842 shares of AstraZeneca worth $2.81M as of Q2 2026.
- Mirae Asset Global Investments sold 4,754 AstraZeneca shares in Q2 2026, an estimated $894K.
- AstraZeneca made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #720 holding.
- Mirae Asset Global Investments first reported a position in AstraZeneca in Q2 2013 and has held it in 53 quarters since.
- Mirae Asset Global Investments's AstraZeneca position peaked at $43.1M in Q1 2024.
- 906 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.